Continuous Glucose Monitoring (CGM) is transforming diabetes care in India, where the disease has reached alarming rates. Continuous Glucose Monitoring is truly a game-changer for diabetes management.

Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) ...

The global injection pen market is poised for significant growth, with projections indicating a robust compound annual growth rate (CAGR) of 7.0% from 2022 to 2033. The market is expected to escalate ...

While hardware revenue is continuing to decline - 58% to $42.4 million in Q3/24 - revenue for sensor ... Medtronic that it is providing both components - the insulin pump as well as the CGM ...

which is part of the Medtronic Cardiovascular Portfolio. "The potential of Affera is limitless. We will continue to fulfill our commitment to innovation, including new indications, to advance ...

Remote monitoring for patients with implanted cardiac electrophysiology devices may finally be coming of age in the U.K. thanks to a review of these systems by the National Institute for Health and ...

Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose ...